genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Special Report
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Cancer
Alpine’s Gold Standard Approach to Drug Development
Biomarkers
Precision M&A: Invitae Eyes Growth in Personalized Cancer Tests, Services with…
Gene Therapy
Obsidian’s SWFT Response to COVID-19
Antibody Drug Conjugates
AbCellera’s CEO: Flattening the Curve of Technology Development
Cancer
After Final Medicare LCD from Palmetto GBA, OncoCyte Pursues Private Coverage…
News
Epigenetics
Epigenetic Clock More Accurately Aligns Dog Age to Human Years
Coronavirus
Newer, More Dominant COVID-19 Variant Is More Infectious in the Lab
Coronavirus
Peptide Drug Discovery Could Lead to a Powerful Anti-Inflammatory
Alzheimers
New Method for Treating Myelin Disorders Discovered
Cancer
Novel Liver Cancer Mechanism Controls Development of Disease
Insights
All
Trends for 2020
Gene Therapy
Moving Forward after Two Deaths in a Gene Therapy Trial of…
Bioprocessing
Bioprocess 4.0 Approach Will Help Biopharma Achieve Regulators’ Goals
Bioprocessing
Digitalized Twin Model of the Workhorse
Bioprocessing
Mitigating Viral Contamination, a Challenge for Emerging Therapies
A-Lists
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Drug Discovery
Top 15 Best-Selling Drugs of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Epigenetics
Epigenetic Clock More Accurately Aligns Dog Age to Human Years
Coronavirus
Newer, More Dominant COVID-19 Variant Is More Infectious in the Lab
Coronavirus
Peptide Drug Discovery Could Lead to a Powerful Anti-Inflammatory
Gene Therapy
Moving Forward after Two Deaths in a Gene Therapy Trial of…
Magazine
All
Special Report
June 2020 Vol. 40 No. 6
The Human Genome Project in 2020 Hindsight
Commentary
3D Microscopy Keeps Getting Faster, Smarter, Leaner
Roundtable
Perspectives on Microscopy
Bioprocessing
Biomanufacturers Cope with Challenges of Going Continuous
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
eBooks
IsoPlexis’ Unique, Predictive Biology
eBooks
Engineering the Immune Response for Therapeutic Success
Upcoming Webinars
Packaging and Producer Cell Lines for Scalable Lentiviral Production
CRISPR-Cas9
GENcast: CRISPR Screens Speed Drug Discovery Efforts for Disease Intervention
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Therapeutics
Pain
Pain
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pain
Blocking Newly Identified Opioid Receptor Points to New Therapeutics for Pain, Depression, and Cancer
Pain
On/Off Pain Control Center Identified in Mouse Brain
Pain
Pain Pathway Study Finds Big Clues in Big Dynorphin
Pain
Purdue Pharma Files for Bankruptcy, in Pursuit of $10B Settlement
Pain
Scorpion Toxin and Wasabi Receptors Help Scientists Unravel Chronic Pain Mechanisms
Pain
High-Tech Imagery May Lead to New Drugs to Treat Therapy-Induced Nausea...
Pain
Gut Microbiome Changes Correlate with Non-Gut Pain
Pain
Opioid Alternative May Be Found in Lethal Pufferfish Toxin
Pain
Lilly Licenses Centrexion Non-Opioid Pain Candidate for Up to $1B
Pain
Insys Shares Plunge After Warning of Chapter 11 Bankruptcy Filing
Pain
Is Fibromyalgia Caused by Insulin Resistance?
Pain
Lundbeck to Acquire Abide for Up to $400M, Bolstering Neurology Pipeline
Pain
Insys Founder, Four Former Executives Convicted of RICO Conspiracy Tied to...
Pain
Pfizer, Lilly Weigh Tanezumab’s Future Following Mixed Phase III Results
Pain
Opiant Eyes Q2 Launch for Pivotal Trial of Opioid Overdose Candidate...
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
